151 related articles for article (PubMed ID: 23612660)
21. Malignant pleural effusion cell blocks are substitutes for tissue in EML4-ALK rearrangement detection in patients with advanced non-small-cell lung cancer.
Zhong J; Li X; Bai H; Zhao J; Wang Z; Duan J; An T; Wu M; Wang Y; Wang S; Wang J
Cytopathology; 2016 Dec; 27(6):433-443. PubMed ID: 27060609
[TBL] [Abstract][Full Text] [Related]
22. EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis.
Su Y; Yi J; Zhang Y; Leng D; Huang X; Shi X; Zhang Y
J Thromb Thrombolysis; 2024 Jan; 57(1):67-81. PubMed ID: 37940761
[TBL] [Abstract][Full Text] [Related]
23. Detection of EML4-ALK fusion gene in Chinese non-small cell lung cancer by using a sensitive quantitative real-time reverse transcriptase PCR technique.
Fu S; Wang F; Shao Q; Zhang X; Duan LP; Zhang X; Zhang L; Shao JY
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):245-54. PubMed ID: 25839699
[TBL] [Abstract][Full Text] [Related]
24. A novel EML4-ALK variant: exon 6 of EML4 fused to exon 19 of ALK.
Penzel R; Schirmacher P; Warth A
J Thorac Oncol; 2012 Jul; 7(7):1198-9. PubMed ID: 22706607
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.
Cruz-Rico G; Avilés-Salas A; Segura-González M; Espinosa-García AM; Ramírez-Tirado LA; Morales-Oyarvide V; Rojas-Marín C; Cardona AF; Arrieta O
Am J Clin Oncol; 2017 Dec; 40(6):631-638. PubMed ID: 26270443
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.
Djalalov S; Beca J; Hoch JS; Krahn M; Tsao MS; Cutz JC; Leighl NB
J Clin Oncol; 2014 Apr; 32(10):1012-9. PubMed ID: 24567430
[TBL] [Abstract][Full Text] [Related]
27. EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.
Martelli MP; Sozzi G; Hernandez L; Pettirossi V; Navarro A; Conte D; Gasparini P; Perrone F; Modena P; Pastorino U; Carbone A; Fabbri A; Sidoni A; Nakamura S; Gambacorta M; Fernández PL; Ramirez J; Chan JK; Grigioni WF; Campo E; Pileri SA; Falini B
Am J Pathol; 2009 Feb; 174(2):661-70. PubMed ID: 19147828
[TBL] [Abstract][Full Text] [Related]
28. Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China.
Li Y; Zhang R; Peng R; Ding J; Han Y; Wang G; Zhang K; Lin G; Li J
J Thorac Oncol; 2016 Jun; 11(6):924-9. PubMed ID: 26988569
[TBL] [Abstract][Full Text] [Related]
29. Detection of Echinoderm Microtubule Associated Protein Like 4-Anaplastic Lymphoma Kinase Fusion Genes in Non-small Cell Lung Cancer Clinical Samples by a Real-time Quantitative Reverse Transcription Polymerase Chain Reaction Method.
Zhao J; Zhao JY; Chen ZX; Zhong W; Li LY; Liu LC; Hu XX; Chen WJ; Wang MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):643-649. PubMed ID: 28065229
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of EML4-ALK gene fusion mutation in patients
with non-small cell lung cancer].
Wang X; Chen W; Yu Y
Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):80-4. PubMed ID: 25676400
[TBL] [Abstract][Full Text] [Related]
31. Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.
Wagner F; Streubel A; Roth A; Stephan-Falkenau S; Mairinger T
J Clin Pathol; 2014 May; 67(5):403-7. PubMed ID: 24293609
[TBL] [Abstract][Full Text] [Related]
32. Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
Ota K; Azuma K; Kawahara A; Hattori S; Iwama E; Tanizaki J; Harada T; Matsumoto K; Takayama K; Takamori S; Kage M; Hoshino T; Nakanishi Y; Okamoto I
Clin Cancer Res; 2015 Sep; 21(17):4014-21. PubMed ID: 26019170
[TBL] [Abstract][Full Text] [Related]
33. Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.
Tanizaki J; Okamoto I; Okabe T; Sakai K; Tanaka K; Hayashi H; Kaneda H; Takezawa K; Kuwata K; Yamaguchi H; Hatashita E; Nishio K; Nakagawa K
Clin Cancer Res; 2012 Nov; 18(22):6219-26. PubMed ID: 22843788
[TBL] [Abstract][Full Text] [Related]
34. Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma.
Wang Q; Yang X; He Y; Ma Q; Lin L; Fu P; Xiao H
J Mol Diagn; 2015 Sep; 17(5):515-20. PubMed ID: 26142544
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
[TBL] [Abstract][Full Text] [Related]
36. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.
Takeuchi K; Choi YL; Togashi Y; Soda M; Hatano S; Inamura K; Takada S; Ueno T; Yamashita Y; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y; Mano H
Clin Cancer Res; 2009 May; 15(9):3143-9. PubMed ID: 19383809
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.
V Laffert M; Warth A; Penzel R; Schirmacher P; Jonigk D; Kreipe H; Schildhaus HU; Merkelbach-Bruse S; Büttner R; Reu S; Kerler R; Jung A; Kirchner T; Wölfel C; Petersen I; Rodriguez R; Jochum W; Bartsch H; Fisseler-Eckhoff A; Berg E; Lenze D; Dietel M; Hummel M
Lung Cancer; 2013 Aug; 81(2):200-6. PubMed ID: 23669200
[TBL] [Abstract][Full Text] [Related]
38. EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation.
Li Y; Li Y; Zhang H; Shi R; Zhang Z; Liu H; Chen J
BMC Pulm Med; 2021 Jun; 21(1):190. PubMed ID: 34090412
[TBL] [Abstract][Full Text] [Related]
39. Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocation.
Tufman AL; Edelmann M; Gamarra F; Reu S; Borgmeier A; Schrödl K; Zauber R; Müller-Lisse U; Huber RM
J Thorac Oncol; 2014 Jan; 9(1):109-13. PubMed ID: 24346098
[TBL] [Abstract][Full Text] [Related]
40. Detection of ALK fusion in lung cancer using fluorescence in situ hybridization.
Kobayashi M; Sonobe M; Takahashi T; Yoshizawa A; Kikuchi R; Date H
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):426-31. PubMed ID: 22879549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
